T. Rowe Price Investment Management
SGRY icon

T. Rowe Price Investment Management’s Surgery Partners SGRY Stock Holding History

T. Rowe Price Investment Management’s Portfolio SGRY Stock Details SGRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$99.4M Buy
5,916,197
+3,966,477
+203% +$55.7M 0.07% 274
2026
Q1 		$23.2M Buy
1,949,720
+1,475,397
+311% +$21.2M 0.02% 452
2025
Q4 		$7.33M Sell
474,323
-24,807
-5% -$456K ﹤0.01% 570
2025
Q3 		$10.8M Buy
+499,130
New +$11.1M 0.01% 554
2022
Q4 		– Sell
-1,037,413
Closed -$24.3M – 568
2022
Q3 		$24.3M Buy
+1,037,413
New +$33.1M 0.02% 428

Other funds holding SGRY

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KSCM
King Street Capital Management New York $190M AUM 16.01% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management's SGRY Position: Q2 2026 in Review

T. Rowe Price Investment Management increased its Surgery Partners (SGRY) stake by 203% in Q2 2026, buying an estimated $55.7M and bringing the position to 5,916,197 shares worth $99.4M. The position accounts for 0.07% of the portfolio, ranked #274.

T. Rowe Price Investment Management first reported a position in SGRY in Q3 2022 and has held it in 5 quarters since. 187 funds tracked by Wall St. Rank hold SGRY as of Q2 2026.

  • T. Rowe Price Investment Management held 5,916,197 shares of Surgery Partners worth $99.4M as of Q2 2026.
  • T. Rowe Price Investment Management bought 3,966,477 Surgery Partners shares in Q2 2026, an estimated $55.7M.
  • Surgery Partners made up 0.07% of T. Rowe Price Investment Management's portfolio in Q2 2026, its #274 holding.
  • T. Rowe Price Investment Management first reported a position in Surgery Partners in Q3 2022 and has held it in 5 quarters since.
  • 187 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.